{"id":"https://openalex.org/W2809686644","doi":"https://doi.org/10.1002/cpdd.588","title":"Clinical Pharmacokinetics and Drug\u2010Drug Interaction Potential for Coadministered SCY\u2010078, an Oral Fungicidal Glucan Synthase Inhibitor, and Tacrolimus","display_name":"Clinical Pharmacokinetics and Drug\u2010Drug Interaction Potential for Coadministered SCY\u2010078, an Oral Fungicidal Glucan Synthase Inhibitor, and Tacrolimus","publication_year":2018,"publication_date":"2018-06-27","ids":{"openalex":"https://openalex.org/W2809686644","doi":"https://doi.org/10.1002/cpdd.588","mag":"2809686644","pmid":"https://pubmed.ncbi.nlm.nih.gov/29947477"},"language":"en","primary_location":{"id":"doi:10.1002/cpdd.588","doi":"https://doi.org/10.1002/cpdd.588","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpdd.588","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpdd.588","source":{"id":"https://openalex.org/S2764863641","display_name":"Clinical Pharmacology in Drug Development","issn_l":"2160-763X","issn":["2160-763X","2160-7648"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology in Drug Development","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpdd.588","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072724821","display_name":"Stephen A. Wring","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Wring","raw_affiliation_strings":["SCYNEXIS, Inc. Jersey City NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc. Jersey City NJ USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085391346","display_name":"Gail M. Murphy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gail Murphy","raw_affiliation_strings":["Riverside Consulting Wilmington DE USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Consulting Wilmington DE USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005485389","display_name":"George J. Atiee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092059","display_name":"Worldwide Clinical Trials (United States)","ror":"https://ror.org/00cj4je85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Atiee","raw_affiliation_strings":["Worldwide Clinical Trials Austin TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Clinical Trials Austin TX USA","institution_ids":["https://openalex.org/I4210092059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004423728","display_name":"Christy Corr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christy Corr","raw_affiliation_strings":["BCH Research Solutions West Chester PA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BCH Research Solutions West Chester PA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037084441","display_name":"Michele Hyman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele Hyman","raw_affiliation_strings":["BCH Research Solutions West Chester PA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BCH Research Solutions West Chester PA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110082290","display_name":"Michael S. Willett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Willett","raw_affiliation_strings":["Ready Clinical LLC Princeton NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ready Clinical LLC Princeton NJ USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103919484","display_name":"David A Angulo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David Angulo","raw_affiliation_strings":["SCYNEXIS, Inc. Jersey City NJ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCYNEXIS, Inc. Jersey City NJ USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103919484"],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":4.199,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.94918662,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"8","issue":"1","first_page":"60","last_page":"69"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.8610000014305115},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8130000233650208},{"id":"https://openalex.org/keywords/candida","display_name":"Candida","score":0.546999990940094},{"id":"https://openalex.org/keywords/aspergillus","display_name":"Aspergillus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fungal-infection","display_name":"fungal infection","score":0.671999990940094},{"id":"https://openalex.org/keywords/azole-antifungals","display_name":"azole antifungals","score":0.6309999823570251},{"id":"https://openalex.org/keywords/tacrolimus-dose-adjustment","display_name":"tacrolimus dose adjustment","score":0.8220000267028809},{"id":"https://openalex.org/keywords/co-administration","display_name":"co-administration","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.8166932463645935},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7748631238937378},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7453871369361877},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6548929810523987},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.4871806502342224},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4561454951763153},{"id":"https://openalex.org/C1621761","wikidata":"https://www.wikidata.org/wiki/Q7997549","display_name":"Whole blood","level":2,"score":0.44197311997413635},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.41811302304267883},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3566133975982666},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.23154550790786743}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005964","descriptor_name":"Glucosyltransferases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014315","descriptor_name":"Triterpenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014315","descriptor_name":"Triterpenes","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014315","descriptor_name":"Triterpenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014315","descriptor_name":"Triterpenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpdd.588","doi":"https://doi.org/10.1002/cpdd.588","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpdd.588","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpdd.588","source":{"id":"https://openalex.org/S2764863641","display_name":"Clinical Pharmacology in Drug Development","issn_l":"2160-763X","issn":["2160-763X","2160-7648"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology in Drug Development","raw_type":"journal-article"},{"id":"pmid:29947477","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29947477","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology in drug development","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1002/cpdd.588","doi":"https://doi.org/10.1002/cpdd.588","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpdd.588","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpdd.588","source":{"id":"https://openalex.org/S2764863641","display_name":"Clinical Pharmacology in Drug Development","issn_l":"2160-763X","issn":["2160-763X","2160-7648"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology in Drug Development","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2809686644.pdf","grobid_xml":"https://content.openalex.org/works/W2809686644.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1986998937","https://openalex.org/W1990267967","https://openalex.org/W2008868978","https://openalex.org/W2010935242","https://openalex.org/W2016292914","https://openalex.org/W2026927296","https://openalex.org/W2034901692","https://openalex.org/W2059392277","https://openalex.org/W2065891345","https://openalex.org/W2086575226","https://openalex.org/W2099312423","https://openalex.org/W2114137379","https://openalex.org/W2117053752","https://openalex.org/W2143849345","https://openalex.org/W2152964734","https://openalex.org/W2165158988","https://openalex.org/W2169076511","https://openalex.org/W2216117396","https://openalex.org/W2260819425","https://openalex.org/W2487631607","https://openalex.org/W2568587140","https://openalex.org/W2582680340","https://openalex.org/W2589939125","https://openalex.org/W2737245802","https://openalex.org/W2802060451"],"related_works":["https://openalex.org/W2582680340","https://openalex.org/W2802060451","https://openalex.org/W2143849345","https://openalex.org/W2586701728","https://openalex.org/W2568587140","https://openalex.org/W2086575226","https://openalex.org/W2090314830","https://openalex.org/W2617660350","https://openalex.org/W2804930666","https://openalex.org/W2075280372"],"abstract_inverted_index":{"SCY-078":[0,43,86,133,164,184,227,291],"is":[1,267,283],"an":[2,13,247],"orally":[3],"bioavailable":[4],"triterpenoid":[5],"glucan":[6],"synthase":[7],"inhibitor":[8],"in":[9,49,67,200,205,212,229,265],"clinical":[10],"development":[11],"as":[12,195,261,276],"intravenous":[14],"and":[15,24,44,150,167,183,208,226,292],"oral":[16,61],"treatment":[17],"of":[18,63,85,96,108,117,132,143,162,170,175,181,193,203,224,240,279,290],"fungal":[19],"infections":[20],"caused":[21],"by":[22,93,140,197],"Candida":[23],"Aspergillus":[25],"species.":[26],"This":[27],"was":[28],"a":[29,59,75,81,114,129,209,230],"sequential,":[30],"single-center,":[31],"open-label":[32],"phase":[33],"1":[34,91,138],"study":[35],"to":[36,157],"assess":[37,158],"the":[38,68,160,168,173,189,216,237,262,270,288],"drug-drug":[39],"interaction":[40,232],"potential":[41],"between":[42],"tacrolimus":[45,64,118,166,171,182,225,252,274],"during":[46],"concomitant":[47],"administration":[48],"healthy":[50],"subjects.":[51],"In":[52,71,124],"cohort":[53,125],"1,":[54,56],"period":[55,72,109],"subjects":[57,79,111,127],"received":[58,80,113,128],"single":[60,82,115],"dose":[62,84,116,131,249],"2":[65,73,102,119,149],"mg":[66,88,99,120,135,146],"fasted":[69],"state.":[70],"after":[74],"\u226515":[76],"day":[77,90,106,137],"washout,":[78],"loading":[83,130],"1250":[87,134],"on":[89,100,136,147,165,172,188],"followed":[92,139],"maintenance":[94,141],"doses":[95,142],"SCY-780":[97,144],"750":[98,145],"days":[101,148],"through":[103],"8.":[104],"On":[105],"3":[107],"2,":[110,126],"also":[112],"concurrent":[121,179,222],"with":[122,236,259,277],"SCY-078.":[123,177],"3.":[151],"Pharmacokinetic":[152],"(PK)":[153],"parameters":[154],"were":[155],"compared":[156],"both":[159],"impact":[161,169],"steady-state":[163,176],"PK":[174],"The":[178,221,242],"coadministration":[180,223,289],"had":[185],"no":[186,198],"effect":[187],"maximum":[190,201],"blood":[191,206],"levels":[192],"tacrolimus,":[194],"evidenced":[196],"change":[199],"concentration":[202],"drug":[204,218],"plasma":[207,217],"1.4-fold":[210],"increase":[211,264],"total":[213],"area":[214],"under":[215],"concentration-time":[219],"curve.":[220],"resulted":[228],"weaker":[231],"than":[233,269],"typically":[234],"observed":[235],"azole":[238],"class":[239],"antifungals.":[241],"current":[243],"data":[244],"indicate":[245],"that":[246],"initial":[248],"adjustment":[250],"for":[251],"may":[253],"not":[254],"be":[255],"warranted":[256],"when":[257],"combined":[258],"SCY-078,":[260],"modest":[263],"exposure":[266],"less":[268],"therapeutic":[271],"window,":[272],"although":[273],"monitoring,":[275],"addition":[278],"any":[280],"new":[281],"medication,":[282],"recommended.":[284],"These":[285],"results":[286],"support":[287],"tacrolimus.":[293]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-07-10T00:00:00"}